SPR
The company aims to leverage its in situ cell-free protein expression system to develop inexpensive, highly multiplexed arrays of full-length folded proteins.
The firm is doubling the capacity of its on-demand ValidaTe microarray over the year and planning to announce a diagnostics spinoff in May.
By Adam Bonislawski
Bio-Rad has developed a workflow linking surface plasmon resonance to MALDI mass spectrometry that could offer a more sensitive and streamlined alternative to conventional SPR-MS techniques.